Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm the large-cap biotech analyst at JPMorgan, and we're delighted to be continuing the conference today with Intra-Cellular. So good news is you don't have to switch rooms for Q&A. I'm going to rerunning the Q&A session at the end of Sharon's presentation. If you want to submit a question to the portal, I got an iPad up here, you can just shoot it over to me, and I will ask it. So with that, let me turn it over to Intra-Cellular CEO, Sharon Mates.
Thank you, Jessica. It's a pleasure to be here today. I'm joined here today with our Chief Commercial Officer, Mark Neumann; and our SVP and Head of Clinical Development, Willie Earley. And during the Q&A, they'll come up here and be on the podium to answer any questions.
So before I start, my presentation today contains forward-looking statements within the meaning of the Private
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
